Short Bowel Syndrome
Gastroenterology·MeSH: Short Bowel Syndrome
Prevalence
5.0 / 100K
5 drugs in development·5 companies·5 clinical trials
Drug Pipeline by Phase
Phase 3(4)
Preclinical(1)
| Drug | Company |
|---|---|
| oral glp-2 | Entera Bio Ltd. (ENTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Short Bowel Syndrome?
BioSniper tracks 5 drugs in development for Short Bowel Syndrome across 5 companies.
How many clinical trials target Short Bowel Syndrome?
There are 5 clinical trials targeting Short Bowel Syndrome tracked by BioSniper.
What is the prevalence of Short Bowel Syndrome?
The estimated prevalence of Short Bowel Syndrome is approximately 5.0 per 100,000 population.
Deep-dive into Short Bowel Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis